Accessible self-requested testing
Awanui is making it easier, and more accessible, for New Zealanders to get the laboratory tests they need through our self-request testing products and services.
BODYiQ
Awanui offers New Zealand’s leading self-request health testing service – BODYiQ, giving people the choice to proactively manage their health without needing a GP referral.
With BODYiQ you can choose from a wide range of tests, including full blood count, cholesterol, hormone profiles, vitamin levels and more, all ordered online. Simply select and order your test online, visit one of our 150+ collection centres nationwide for your test, and receive your results securely online within days.
BODYiQ also supports people focused on fitness, recovery, and performance, helping you understand nutrient levels, hormones, and markers linked to energy, stress, and muscle strength. It’s a simple, trusted way to keep track of your health on your terms.
Find out more at bodyiq.co.nz.
BODYiQ STI Test Kit
The BODYiQ STI Test Kit offers a confidential and convenient way to access laboratory STI testing. Available online without a referral, it connects New Zealanders to trusted testing through Awanui’s nationwide laboratory network.
The service supports proactive sexual health screening with secure online ordering, professional laboratory analysis, and confidential delivery of results. By making testing more accessible, BODYiQ helps people take greater control of their health and wellbeing.
Find out more at bodyiq.co.nz.
Non-invasive prenatal screening (NIPS)
Commonly known as NIPT
Non-invasive prenatal screening test, often referred to as NIPT, available through Awanui is called Illumiscreen and is the only screening of its type available in Aotearoa New Zealand where your blood sample remains in the country. The prenatal screen is available anywhere in the country to any pregnant person with a referral from their midwife, GP or other lead maternity carer.
Illumiscreen analyses all 23 chromosome pairs for genetic conditions of an unborn baby, using a single blood test, and as early as 10 weeks of pregnancy.
Not only can we screen for Down syndrome, Edwards syndrome and Patau syndrome but our whole-genome sequencing technology means we can screen for more conditions such as Jacob syndrome, Triple-X, Angelman, DiGeorge, Prader-Willi syndrome and Wolf-Hirschhorn syndrome.
The confidential report will indicate if there is an increased chance the pregnancy has a chromosomal condition. To confirm an increased chance result from this screen, a diagnostic test such as amniocentesis or chorionic callus sampling (CVS) is still necessary.
Illumiscreen is backed by genetic counselors to support midwives and healthcare providers through reporting results to their patients.
You can find out more about Illumiscreen at illumiscreen.co.nz.
